Antibody-based proteomics: fast-tracking molecular diagnostics in oncology

Area of Science:

• Proteomics
• Cancer Biology
• Biomarker Discovery

Background:

• Personalized cancer therapy relies on identifying effective biomarkers for clinical decisions.
• Antibody-based proteomics is crucial for high-throughput evaluation of potential cancer markers.
• Traditional antibody use in diagnostics suggests rapid translation of proteomics approaches is feasible.

Purpose of the Study:

• To review the current status of antibody-based proteomics.
• To highlight its role in developing new assays for individualized cancer therapy.
• To discuss its contribution alongside genomic and transcriptomic methods for patient stratification.

Main Methods:

• Review of current literature on antibody-based proteomics.
• Analysis of antibody-based proteomics in biomarker discovery and validation pipelines.
• Comparison with genomic and transcriptomic approaches for cancer patient stratification.

Main Results:

• Antibody-based proteomics facilitates high-throughput candidate marker evaluation.
• This technology offers potential for additional insights into cancer disease states.
• It contributes to developing crucial assays for personalized cancer treatment.

Conclusions:

• Antibody-based proteomics is pivotal for personalized cancer therapy realization.
• It supports biomarker identification and validation, aiding clinical decision-making.
• This field offers a promising avenue for advancing individualized cancer treatment strategies.